<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01572623</url>
  </required_header>
  <id_info>
    <org_study_id>2011-005330-18</org_study_id>
    <nct_id>NCT01572623</nct_id>
  </id_info>
  <brief_title>Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting</brief_title>
  <acronym>ARMYDA-CARO</acronym>
  <official_title>Efficacy of Two Different Pre-Intervention Therapeutic Strategies With Clopidogrel and Atorvastatin for the Prevention of Cerebral Damage During Carotid Artery Stenting. Armyda-Caro Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Campus Bio-Medico University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of two different loading
      doses of Clopidogrel and a reloading of Atorvastatin in the prevention of periprocedural
      ischemic brain damage in patients undergoing carotid angioplasty.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral damage</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of stroke at 30 days (defined as a neurologic deficit lasting&gt; 24 hours with MRI evidence of cerebral ischemic injury) or transient ischemic attack (TIA);
- Evidence of new onset acute ischemic lesions on MRI-DWI brain after the procedure, even in the absence of specific neurological symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding complications</measure>
    <time_frame>30 days</time_frame>
    <description>Effect on the 30-day major and minor bleeding (according to the TIMI definition);
- Incidence of post-procedural vascular complications (pseudoaneurysm, AV fistula, hematoma&gt; 5 cm).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Antiplatelet before carotid artery stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clopidogrel 600 mg after carotid artery stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Statin therapy before carotid artery stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Reloading dose of Atorvastatin (80 mg at 12 hours and 40 mg at 6-8 hours before carotid artery stenting) versus no reload.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel</intervention_name>
    <description>Loading dose of Clopidogrel 600 mg versus 300 mg before carotid artery stenting</description>
    <arm_group_label>Antiplatelet before carotid artery stenting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>Reloading dose of Atorvastatin (80 mg at 12 hours and 40 mg at 6-8 hours before carotid artery stenting) versus no reload.</description>
    <arm_group_label>Statin therapy before carotid artery stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic and asymptomatic patients with finding of significant carotid stenosis

        Exclusion Criteria:

          -  patients with acute injuries to the baseline MRI of the brain,

          -  patients with active bleeding,

          -  contraindications to statin therapy and MRI contraindications
             (pacemaker/claustrophobic).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patti Giuseppe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Campus Bio-Medico University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Patti, MD</last_name>
    <phone>06225411899</phone>
    <email>g.patti@unicampus.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Campus Bio Medico University of Rome</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patti Giuseppe, MD</last_name>
      <phone>06225411899</phone>
      <email>g.patti@unicampus.it</email>
    </contact>
    <investigator>
      <last_name>Melfi Rosetta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Macr√¨ Michele, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Picarelli Silvia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2012</study_first_submitted>
  <study_first_submitted_qc>April 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2012</study_first_posted>
  <last_update_submitted>April 5, 2012</last_update_submitted>
  <last_update_submitted_qc>April 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Campus Bio-Medico University</investigator_affiliation>
    <investigator_full_name>Patti Giuseppe</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Therapeutic strategies for carotid artery stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
    <mesh_term>Ticlopidine</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

